AIM IMMUNOTECH INC. Current Liabilities
AIM IMMUNOTECH INC. (AIM) had Current Liabilities of $4.95 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $4.95M.
- 2026-03-31: Liabilities, Current $6.14M.
- 2025-12-31: Liabilities, Current $6.22M.
- 2025-09-30: Liabilities, Current $4.04M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $4.95M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $6.14M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $6.22M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $4.04M 10-Q · filed 2025-11-17 |
| 2025-06-30 | $10.39M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $9.77M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $9.54M 10-K · filed 2026-03-27 |
| 2024-09-30 | $10.10M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $8.84M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $9.88M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.65M 10-K · filed 2025-03-27 |
| 2023-09-30 | $4.72M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.88M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.84M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.36M 10-K · filed 2024-04-01 |
| 2022-09-30 | $2.90M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.37M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $766.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $673.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $767.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $876.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $970.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.10M 10-K · filed 2022-03-31 |
| 2020-09-30 | $795.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $833.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $703.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.13M 10-K · filed 2021-03-31 |
| 2019-09-30 | $4.19M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.75M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.09M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $5.29M 10-K · filed 2020-03-30 |
| 2018-09-30 | $4.96M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.08M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.65M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.71M 10-K · filed 2019-04-01 |
| 2017-09-30 | $2.20M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $2.74M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.64M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.44M 10-K · filed 2018-03-30 |
| 2016-09-30 | $2.43M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.43M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $3.09M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $2.43M 10-K · filed 2017-03-31 |
| 2015-09-30 | $3.33M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $3.10M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $3.82M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $4.44M 10-K · filed 2016-03-29 |
| 2014-09-30 | $4.26M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $4.16M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $2.99M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $2.53M 10-K · filed 2015-03-19 |
| 2013-09-30 | $10.63M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $9.86M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $10.03M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $12.65M 10-K · filed 2014-03-14 |
| 2012-09-30 | $9.79M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $7.36M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $5.98M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $5.07M 10-K · filed 2013-03-18 |
| 2011-09-30 | $3.60M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $1.95M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $2.83M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |